Literature DB >> 16263121

A proteomic snapshot of the human heat shock protein 90 interactome.

S Fabio Falsone1, Bernd Gesslbauer, Florian Tirk, Anna-Maria Piccinini, Andreas J Kungl.   

Abstract

Heat shock protein 90 (Hsp90) is a molecular chaperone which modulates several signalling pathways within a cell. By applying co-immunoprecipitation with endogeneous Hsp90, we were able to identify 39 novel protein interaction partners of this chaperone in human embryonic kidney cells (HEK293). Interestingly, levels of DNA-activated protein kinase catalytic subunit, an Hsp90 interaction partner found in this study, were found to be sensitive to Hsp90 inhibitor treatment only in HeLa cells but not in HEK293 cells referring to the tumorgenicity of this chaperone.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16263121     DOI: 10.1016/j.febslet.2005.10.020

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  45 in total

1.  A chemical cross-linking method for the analysis of binding partners of heat shock protein-90 in intact cells.

Authors:  Shaoming Song; Sutapa Kole; Michel Bernier
Journal:  Biotechniques       Date:  2012-04       Impact factor: 1.993

2.  The expanding proteome of the molecular chaperone HSP90.

Authors:  Rahul S Samant; Paul A Clarke; Paul Workman
Journal:  Cell Cycle       Date:  2012-04-01       Impact factor: 4.534

Review 3.  HSP90AB1: Helping the good and the bad.

Authors:  Michael Haase; Guido Fitze
Journal:  Gene       Date:  2015-09-07       Impact factor: 3.688

4.  Novel Hsp90 partners discovered using complementary proteomic approaches.

Authors:  Pavel A Tsaytler; Jeroen Krijgsveld; Soenita S Goerdayal; Stefan Rüdiger; Maarten R Egmond
Journal:  Cell Stress Chaperones       Date:  2009-04-26       Impact factor: 3.667

Review 5.  Proteomic identification of multitasking proteins in unexpected locations complicates drug targeting.

Authors:  Georgina S Butler; Christopher M Overall
Journal:  Nat Rev Drug Discov       Date:  2009-12       Impact factor: 84.694

6.  A proteomic investigation of ligand-dependent HSP90 complexes reveals CHORDC1 as a novel ADP-dependent HSP90-interacting protein.

Authors:  Jacob J Gano; Julian A Simon
Journal:  Mol Cell Proteomics       Date:  2009-10-28       Impact factor: 5.911

7.  C1206, a novel curcumin derivative, potently inhibits Hsp90 and human chronic myeloid leukemia cells in vitro.

Authors:  Ying-Juan Fan; Yi-Xiang Zhou; Lian-Ru Zhang; Qiao-Fa Lin; Ping-Zhang Gao; Fang Cai; Li-Ping Zhu; Bi Liu; Jian-Hua Xu
Journal:  Acta Pharmacol Sin       Date:  2017-12-07       Impact factor: 6.150

Review 8.  New developments in Hsp90 inhibitors as anti-cancer therapeutics: mechanisms, clinical perspective and more potential.

Authors:  Yanyan Li; Tao Zhang; Steven J Schwartz; Duxin Sun
Journal:  Drug Resist Updat       Date:  2009 Feb-Apr       Impact factor: 18.500

9.  Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin inhibits the proliferation of ARPE-19 cells.

Authors:  Jia-Qi Yao; Qing-Huai Liu; Xi Chen; Qin Yang; Zhi-Yang Xu; Fan Hu; Lin Wang; Jian-Min Li
Journal:  J Biomed Sci       Date:  2010-04-23       Impact factor: 8.410

10.  Ligand and protein fishing with heat shock protein 90 coated magnetic beads.

Authors:  M P Marszałł; R Moaddel; S Kole; M Gandhari; M Bernier; I W Wainer
Journal:  Anal Chem       Date:  2008-08-12       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.